Prednisone Completed Phase 2 Trials for Relapsing Remitting Multiple Sclerosis (RRMS) / Disseminated Sclerosis Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00288626High-Dose Immunosuppression and Autologous Transplantation for Multiple Sclerosis (HALT MS) Study